Best sites for transcutaneous bilirubin in preterm infants: forehead, sternum, abdomen, pretrial, and ankle

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250611002

Enrollment

120

Registered

2025-06-11

Start date

2025-06-16

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Measurement of transcutaneous bilirubin at different sites and total serum bilirubin in preterm neonates Total serum bilirubin, Transcutaneous bilirubin

Interventions

Preterm infants exhibiting jaundice symptoms must be examined for a jaundice test. After explaining to parents the purpose and methodology of the research endeavour including parental permission. When

Screening

Value of transcutaneous bilirubin at different sites

Eligibility

Sex/Gender

All

Age

1 Days to 30 Days

Inclusion criteria

Inclusion criteria: Preterm with jaundice

Exclusion criteria

Exclusion criteria: Skin lesions

Design outcomes

Primary

Measure	Time frame
Value of transcutaneous bilirubin 24 months mg/dL	—

Secondary

Measure	Time frame
Analysis of the accuracy of the TCB at different sites for jaundice in practice 24 months mg/dL	—

Countries

Thailand

Contacts

Public ContactNanthida Phattraprayoon

Chulabhorn Royal Academy

nanthida.pha@cra.ac.th0886247388

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026